期刊文献+

去唾液酸糖蛋白受体介导的肝靶向脂质体配体的酶促催化合成研究 被引量:4

Study on the Enzyme-Catalyzed Synthesis of Ligands for ASGPR-mediated Liver Targeting Liposomes
原文传递
导出
摘要 目的用酶促催化乳糖酸与十八胺合成一种可用于镶嵌脂质体表面的去唾液酸糖蛋白靶向配体修饰物。方法通过红外光谱(IR)、质谱(ESI-MS)和核磁共振(1H-NMR)对产物结构进行确证,并对酶种类、反应介质、酶的加入量、底物摩尔比、反应温度等影响因素进行考察。结果二甲基亚砜作为反应介质;Novozym 435固定化脂肪酶作为催化剂、酶加入量为400U.mL-1、乳糖酸和十八胺的摩尔比为2∶1、40℃下反应24 h,十八胺的转化率可达99%以上。结论酶促催化法可用来合成肝靶向脂质体配体。 OBJECTIVE To synthesize asialoglycoprotein receptor ligand-targeted modifier which is used to insert the surface of liposome by enzyme-catalyzed amidation of laetobionic acid and stearamine. METHODS The structure of the product was confirmed by IR, ESI-MS and ^1H-NMR. The effects of types and quantity of enzyme, organic solvents, molar ratio of substrate and temperature of reaction were studied. RESULTS When using DMSO as reaction medium, Novozym 435 immobilized lipase at 400 U·mL^-1 , molar ratio of lactobionie acid to stearamine at 2: 1, and reacting at 40 ℃ for 24 h, the transformation of stearamine reached more than 99%. CONCLUSION The enzyme catalysis is useful for synthesizing liver targeting liposomes.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第1期40-43,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30772790) 广东省自然科学基金资助项目(S2011040003133)
关键词 酶促催化 去唾液酸糖蛋白受体 配体 十八胺 enzyme-catalyzed asialoglycoprotein receptor ligand stearamine
  • 相关文献

参考文献9

  • 1FALLON R J, SCHWARTZ A L. Receptor-mediated delivery of drugs to hepatocytes [J]. Adv Drug Deliv Rev, 1989, 4(2) : 49- 63.
  • 2DONATI I, GAMINI A, VETERE A, et al. Synthesis, characterization, and preliminary biological study of glycoconjugates of poly (styrene-co-maleicacid) [J]. Biomacromolecules, 2002, 3 (4): 805-812.
  • 3WU J, NANTZ M H, ZERN M A. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and application [J]. Front Biosci, 2002, 7(3) :d717-725.
  • 4STOCKERT R J. The asialoglyeoprotein receptors: relationships between structure, function, and expression [J]. Physiol Rev, 1995, 75(3) : 591-593.
  • 5WANG S N, DENG Y H, XU H, et al. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin [ J ]. Eur J Pharm Biopharm, 2006, 62(1 ) :32-38.
  • 6路姣,孙逊,海俐,吴勇,张志荣.半乳糖化脂质体-聚阳离子-DNA复合物的肝靶向性研究[J].华西药学杂志,2007,22(3):239-241. 被引量:2
  • 7KIM C K, MIN K H, OH Y K, et al. Preparation and lectin binding characteristics of N-stearyl lactobionamide liposomes [ J ]. Int J Pharm, 1996, 128(1-2) : 65-71.
  • 8LEE M Y, DORDICK J S. Enzyme activation for nonaqueous media [J]. Curr Opin Biotech, 2002, 13 (4) : 376-384.
  • 9吴春燕,李春秀.气相色谱法测定十八胺[J].合成润滑材料,2005,32(3):12-14. 被引量:8

二级参考文献7

  • 1周良模.气相色谱新技术[M].北京:科学出版社,1998.256-258.
  • 2Wu GY,Wu CH.Receptor-mediated delivery of foreign genes to hepatocytes[J].Adv Drug Deliv Rev,1998,29:243-248.
  • 3Brawn JR,Willnow TE,Ishibashi S,et al.The major subunit of the asisloglycoprotein receptor is expressed on the heptacellular surfate in mice lacking the minor receptor subunit[J].J Biol Chem,1996,270:21160-21166.
  • 4Sun X,Hai L,Wu Y,et al.Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD)[J].J Drug Targeting,2005,13(2):121-128.
  • 5Shigeru K,Shintaro F,Makiya N,et al.In vivo gene delivery to the liver using novel galactosylated cationic liposomes[J].Pharm Res,2000,17(3):306-313.
  • 6Bider MD,Spiess M.Ligand-induced endocytosis of the asialoglycoprotein receptor:evidence for heterogeneity in subunit oligomerization[J].FEBS Letters,1998:37-41.
  • 7傅志君,徐希明,尤启冬.无唾液酸糖蛋白受体介导的肝靶向药物[J].药学进展,1998,22(4):204-211. 被引量:2

共引文献8

同被引文献65

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部